All the news

Screening people admitted to hospital with COVID-19 for hepatitis C or hepatitis B does not lead to detection of a large number of undiagnosed infections and is likely to be of limited ...

People who have undergone a solid organ transplant and who received the Pfizer or Moderna COVID-19 vaccines should receive a third dose, the US Centers for Disease Control and Prevention (CDC) recommended ...

Liver transplant recipients in Israel were less likely to develop antibodies after a second dose of the Pfizer SARS-CoV-2 vaccine than healthy volunteers, transplant specialists from Tel Aviv’s Sourasky Medical Center report in ...

Among people with non-alcoholic fatty liver disease (NAFLD), those with more advanced liver fibrosis did not respond as well to the Pfizer-BioNTech COVID-19 vaccine, according to study results presented at the 2021 International ...

People with advanced cirrhosis or alcohol use disorder were significantly more likely to die from COVID-19 in France during 2020 compared to the rest of the population, a study of the French ...

People taking tenofovir (Viread) as treatment for hepatitis B were significantly less likely to suffer severe COVID-19 or to need mechanical ventilation after admission to hospital than people taking the alternative hepatitis B ...

The COVID-19 pandemic severely reduced hepatitis C testing, diagnosis and treatment in the United States during 2020, a study by Quest Diagnostics and the US Centers for Disease Control and Prevention (CDC) ...

Outreach to homeless people in England housed in temporary accommodation during the COVID-19 pandemic led to over 1200 to be tested for hepatitis C, one in ten to test positive for active ...